Full Paper
doi.org/10.1002/chem.202002801
Chemistry—A European Journal
water. A saturated aqueous solution of KPF6 (234 mg, 1.27 mmol,
2.48 equiv) was added under stirring. The formed precipitate was
filtered off, washed with 5 mL water, twice with 5 mL diethyl ether
each and dried in vacuo to obtain 7 as an air stable off-white solid
(204 mg, 388 mmol, 74%). 1H NMR (400 MHz, CD3CN): d [ppm]=
3.59 (s, 6H, NCH3), 2.36 (s, 6H, CCH3). 13C{1H} NMR (100 MHz,
CD3CN): d [ppm]=134.0 (CCH3), 124.2 (NCN, signal from HMBC),
34.8 (NCH3), 9.4 (CCH3). MS (ESI+, CH3CN): m/z=124.1 [M]2+, 393.2
which the color turned orange. After stirring for 1 h LiHMDS
(65.2 mg, 390 mmol, 2 equiv) was added as solid together with
2 mL acetonitrile. After stirring for 1 h at room temperature, the
dark orange solution was concentrated in vacuo to 2 mL and
10 mL degassed water were added. After stirring for 30 min, the
formed brown precipitate was filtered off and dissolved in 2 mL of
acetonitrile. 30 mL of diethyl ether were added to precipitate the
product, which was filtered off, washed with 5 mL diethyl ether
and dried in vacuo. The brown air stable product (84.2 mg,
117 mmol, 60%) is a mixture of both isomers 12 and 13 in 4.5:1
ratio. Crystals suitable for X-ray analysis of 12 (orange plates) and
13 (oranges blocks) were obtained by diffusion of diethyl ether
[M+PF6]2+
.
Synthesis of 9: To a suspension of TlCp (237 mg, 1.01 mmol,
3.05 equiv) in 4 mL acetonitrile a solution of N,N’-di(n-propyl)-1,8-
dichlorodiimidazo[1,5-b:5’,1’-f]pyridazinium
di(hexafluorophos-
1
into a solution of the product mixture in acetonitrile. 12: H NMR
phate) (8) (200 mg, 0.332 mmol, 1 equiv) in 6 mL of acetonitrile
was added. After stirring for 72 h in the dark, the reaction mixture
turned yellow and a grey precipitate had formed. The solid was fil-
tered off and the solvent removed in vacuo. The residue was dis-
solved in 10 mL acetonitrile and 20 mL of degassed water was
added to precipitate the yellow raw material, which was filtered
off, dissolved in 1.5 mL acetonitrile and 30 mL of ethyl ether were
added. The obtained yellow solid was filtered off again, dissolved
in 5 mL acetonitrile and 40 mL degassed water were added. The
yellow precipitate was filtered off, washed with 3 mL degassed
water and dried in vacuo. The product 9 was obtained as a yellow,
air-stable solid (108 mg, 0.240 mmol, 72%). Crystals suitable for X-
ray analysis were obtained by overlaying a solution of 9 in di-
(600 MHz, CD3CN): d [ppm]=7.35 (s, 2H, H-2/5), 7.09 (s, 2H, H-7/9),
6.87 (s, 2H, H-3/4), 4.37 (t, 3JHH =7.0 Hz, 4H, NCH2), 3.65 (s, 6H,
NCH3), 2.30 (s, 6H, CCH3), 1.96 (tq, 4H, 3JHH =7.4 Hz, 3JHH =7.0 Hz,
3
CH2), 1.00 (t, 6H, JHH =7.4 Hz, CH3). 13C{1H} NMR (151 MHz, CD3CN):
d [ppm]=143.2 (C-10), 132.9 (C-6a/9b), 127.4 (CCH3), 121.3 (C-2a/
4a), 116.3 (C-3/4), 116.1 (C-2/5), 116.0 (C-6b/9a), 113.1 (s, C-7/9),
106.2 (C-8), 51.6 (NCH2), 34.0 (NCH3), 23.7 (CH2), 10.9 (CH3), 9.1
1
(CCH3). 13: H NMR (600 MHz, CD3CN): d [ppm]=7.34 (s, 1H, H-2),
3
3
7.24 (s, 1H, H-5), 7.12 (d, 1H, JHH =4.2 Hz, H-9), 6.84 (d, 1H, JHH
=
4.2 Hz, H-8), 6.83 (s, 1H, H-3 or H-4), 6.80 (s, 1H, H-3 or H-4), 4.40–
b
a
4.37 (m, 2H, NCH2 ), 3.50 (s, 6H, NCH3), 3.18–3.15 (m, 2H, NCH2 ),
b
a
2.33 (s, 6H, CCH3), 2.02–1.96 (m, 2H, CH2 ), 1.59–1.53 (m, 2H, CH2 ),
1.04 (t, 3H, 3JHH =7.3 Hz, CH3 ), 0.71 (t, 3H, 3JHH =7.3 Hz, CH3 ).
13C{1H} NMR (151 MHz, CD3CN): d [ppm]=142.6 (C-10), 128.6
(CCH3), 127.9 (C-8), 116.5 (C-3 or C-4), 116.3 (C-3 or C-4), 116.2 (C-2),
b
a
chloromethane with pentane. 1H NMR (400 MHz, CD3CN):
d
3
[ppm]=7.16 (s, 2H, H-2/5), 6.91 (d, 2H, JHH =3.8 Hz, H-7/9), 6.77 (t,
3
3
1H, JHH =3.8 Hz, H-8), 6.73 (s, 2H, H-3/4), 4.29 (t, 4H, JHH =7.2 Hz,
NCH2), 1.96 (tq, 4H, 3JHH =7.4 Hz, 3JHH =7.2 Hz, CH2), 1.00 (t, 6H,
3JHH =7.4 Hz, CH3). 13C{1H} NMR (100 MHz, CD3CN): d [ppm]=133.2
(C-6a/9b), 124.9 (C-8), 120.8 (C-2a/4a), 115.9 (C-3/4), 115.0 (C-2/5),
111.9 (C-7/9), 104.7 (C-6b/9a), 51.2 (NCH2), 23.7 (CH2), 11.0 (CH3).
19F{1H} NMR (376 MHz, CD3CN): d [ppm]=ꢀ72.9 (d, 1JPF =707 Hz,
b
a
116.1 (C-5), 112.7 (C-9), 51.6 (NCH2 ), 51.6 (NCH2 ), 33.7 (NCH3), 23.7
b
a
b
a
(CH2 ), 23.4 (CH2 ), 10.9 (CH3 ), 10.8 (CH3 ), 9.1 (CCH3). The signals
for C-2a, C-4a, C-6a, C-6b, C-7, C-9a and C-9b could not be as-
signed unambiguously. Both: 19F{1H} NMR (376 MHz, CD3CN): d
1
[ppm]=ꢀ72.9 (d, JPF =707 Hz, PF6). 31P{1H} NMR (162 MHz, CD3CN):
1
1
d [ppm]=ꢀ144.6 (spt, JPF =707 Hz, PF6). MS (ESI+, CH3CN): m/z=
PF6). 31P{1H} NMR (162 MHz, CD3CN): d [ppm]=ꢀ144.6 (spt, JPF
=
1
214.0 [M]2+. MS (ESIꢀ, CH3CN): m/z=144.8 [PF6]ꢀ.
707 Hz, PF6). H NMR (400 MHz, CD2Cl2): d [ppm]=7.08 (s, 2H, H-2/
5), 6.93–6.89 (m, 3H, H-7/9 and H-8), 6.73 (s, 2H, H-3/4), 4.29 (t, 4H,
3JHH =7.3 Hz, NCH2), 2.01 (tq, 4H, 3JHH =7.4 Hz, 3JHH =7.3 Hz, CH2),
Synthesis of 12-d2 and 13-d2: To a solution of the above obtained
mixture of 12 and 13 (20.0 mg, 27.8 mmol, 1 equiv) in 0.4 mL of
CD3CN were added 100 mL D2O (111 mg, 5.54 mmol, 199 equiv).
The mixture is then heated for 8 d at 608C. The solvent was re-
moved in vacuo and the residue dissolved in 0.4 mL of CD3CN and
3
1.08 (t, 6H, JHH =7.4 Hz, CH3). CHN: calcd C 50.67, H 4.70, N 12.44
found C 50.64, H 4.95, N 12.18. MS (ESI+, CH3CN): m/z=305.2 [M]+.
MS (ESIꢀ, CH3CN): m/z=144.8 [PF6]ꢀ. UV/VIS (CH3CN): l1 =284 nm
(e=2.2ꢃ104 Lmolꢀ1·cmꢀ1), l2 =339 nm (e=1.1ꢃ104 Lmolꢀ1·cmꢀ1).
IR (KBr): v˜ [cmꢀ1]=2971 (w), 2920 (w), 1630 (m), 1587 (m), 1459
(w), 1386 (w), 1308 (w), 1343 (w), 1308 (w), 1160 (w), 1047 (w),
1024 (w), 841 (vs., PF6ꢀ), 792 (w), 733 (w), 722 (w), 558 (s, PF6ꢀ).
Mp.: 2028C (dec.).
1
filtered. 12: H NMR (400 MHz, CD3CN): d [ppm]=7.36 (s, residual
proton signal, H-2/5), 7.10 (s, 2H, H-7/9), 6.87 (s, 2H, H-3/4), 4.38 (t,
3JHH =7.0 Hz, 4H, NCH2), 3.66 (s, 6H, NCH3), 2.30 (s, 6H, CCH3), 1.98
(tq, 4H, 3JHH =7.4 Hz, 3JHH =7.0 Hz, CH2), 1.01 (t, 6H, 3JHH =7.4 Hz,
CH3). 13C{1H} NMR (100 MHz, CD3CN): d [ppm]=143.2 (C-10), 132.8
(C-6a/9b), 127.3 (CCH3), 121.2 (C-2a/4a), 116.2 (C-3/4), 116.0 (C-6b/
9a), 113.1 (C-7/9), 106.2 (C-2), 51.6 (NCH2), 34.0 (NCH3), 23.6 (CH2),
10.9 (CH3), 9.1 (CCH3). The signal for C-2/5 could not be detected.
Synthesis of 9-d2: To a solution of 9 (23.0 mg, 51.1 mmol, 1 equiv)
in 0.4 mL of CD3CN 92 mL D2O (102 mg, 5.11 mmol, 100 equiv) were
added. The mixture was then heated for 24 h at 608C. The solvent
was removed in vacuo and the residue dissolved in 0.4 mL of
13: 1H NMR (400 MHz, CD3CN): d [ppm]=7.34 (s, residual proton
3
CD3CN and the solution filtered. 1H NMR (400 MHz, CD3CN): d
signal, H-2), 7.24 (s, residual proton signal, H-5), 7.11 (d, 1H, JHH
=
3
3
4.3 Hz, H-9), 6.84 (d, 1H, JHH =4.3 Hz, H-8), 6.82 (s, 1H, H-3 or H-4),
6.80 (s, 1H, H-3 or H-4), 4.41–4.37 (m, 2H, NCH2 ), 3.50 (s, 6H,
NCH3), 3.18–3.14 (m, 2H, NCH2 ), 2.33 (s, 6H, CCH3), 2.02–1.96 (m,
[ppm]=7.16 (s, residual proton signal, H-2/5), 6.89 (d, 2H, JHH
=
b
3.8 Hz, H-7/9), 6.76 (t, 1H, 3JHH =3.8 Hz, H-8), 6.72 (s, 2H, H-3/4),
a
3
4.28 (t, 4H, 3JHH =7.2 Hz, NCH2), 1.95 (tq, 4H, 3JHH =7.4 Hz, JHH
=
b
a
3
b
7.2 Hz, CH2), 1.00 (t, 6H, JHH =7.4 Hz, CH3). 13C{1H} NMR (100 MHz,
3
2H, CH2 ), 1.61–1.51 (m, 2H, CH2 ), 1.04 (t, 3H, JHH =7.3 Hz, CH3 ),
0.71 (t, 3H, 3JHH =7.3 Hz, CH3 ). The 13C signals could not be as-
a
CD3CN): d [ppm]=133.1 (C-6a/9b), 124.9 (C-8), 120.7 (C-2a/4a),
signed unambiguously due to the low intensity. Both: MS (ESI+,
1
115.8 (C-3/4), 115.0 (C-2/5), 114.8 (t, JCD =31.2 Hz, C-2/5), 111.9 (C-
CH3CN): m/z=215.1 [M]2+
,
575.2 [M+PF6]+. The deuteration
7/9), 104.7 (C-6b/9a), 51.2 (NCH2), 23.7 (CH2), 11.0 (CH3). MS (ESI+,
CH3CN): m/z=307.2 [M]+. The deuteration degree of 93% was de-
termined from the ESI-spectrum.
degree of 97% was determined from the ESI-spectrum.
Modified synthesis of 1,2,3,4,5-pentamethylruthenocene (15):[29,53]
To a suspension of LiCp (15.0 mg, 208 mmol, 1.05 equiv) in 2 mL of
acetonitrile a solution of [Ru(CH3CN)3Cp*](PF6) (100 mg, 198 mmol,
1 equiv) in 1 mL of acetonitrile was added under stirring. After
10 min, the solvent of the formed solution was removed in vacuo,
Synthesis of 12 and 13: To a solution of N,N’-di(n-propyl)-1,8-di-
chlorodiimidazo[1,5-b:5’,1’-f]pyridazinium di(hexafluorophosphate)
(7) (118 mg, 195 mmol, 1 equiv) in 2 mL acetonitrile, a solution of 2
(36.7 mg, 195 mmol, 1 equiv) in 2 mL acetonitrile is added upon
&
&
Chem. Eur. J. 2020, 26, 1 – 16
12
ꢁ 2020 The Authors. Published by Wiley-VCH GmbH
ÝÝ These are not the final page numbers!